Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| ent-Naxagolide Hydrochloride | (4aS-trans)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol Hydrochloride; (-)-Propyl-9-hydroxynaphthoxazine Hydrochloride;(-)-PHNO | 100935-99-7 | C15H22ClNO2 | 283.79 | (4aS-trans)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol Hydrochloride; (-)-Propyl-9-hydroxynaphthoxazine Hydrochloride;(-)-PHNO... |
| Nateglinide Ethyl Ester | N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine Ethyl Ester; | 187728-85-4 | C21H31NO3 | 345.48 | N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine Ethyl Ester;
|
| Nateglinide-d5 Ethyl Ester | N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-(phenyl-d5)alanine Ethyl Ester; | 1356929-50-4 | C21H26D5NO3 | 350.51 | N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-(phenyl-d5)alanine Ethyl Ester;
|
| Na+/H+ Exchanger Isoform-1 Inhibitor | 861218-38-4 | C11H8N4OS CH4O3S | 244.27 | ||
| NB-851 | (4S)-4-[(1R)1-Hydroxy-2-[[1-[3-(1-methylethyl)phenyl]cyclopropyl]amino]ethyl]-19-methyl-11,16-dioxa-3,18-diazatricyclo[15.3.1.16,10]docosa-1(21),6,8,10(22),17,19-hexaen-2-one; (4S)-4-[(1R)-1-Hydroxy-2-[[1-(3-isopropylphenyl)cyclopropyl]amino]ethyl]-19-methyl-11,16-dioxa-3,18-diazatricyclo[15.3.1.16,10]docosa-1(21),6,8,10(22),17,19-hexaen-2-one; | 943925-09-5 | C33H41N3O4 | 543.7 | (4S)-4-[(1R)1-Hydroxy-2-[[1-[3-(1-methylethyl)phenyl]cyclopropyl]amino]ethyl]-19-methyl-11,16-dioxa-3,18-diazatricyclo[15.3.1.16,10]docosa-1(21),6,8,1... |
| C-6 NBD Ceramide | 2,1,3-Benzoxadiazole Hexanamide deriv.; N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide; NBD C6-ceramide; N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-4-benzofurazanyl)amino]-hexanamide; N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide | 86701-10-2 | C30H49N5O6 | 575.74 | 2,1,3-Benzoxadiazole Hexanamide deriv.; N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide; NBD C... |
| C-6 NBD-dihydro-Ceramide | 2,1,3-Benzoxadiazole Hexanamide deriv.; [R-[R,R-(E)]]-N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-4-benzofurazanyl)amino]-hexanamide | 114301-95-0 | C30H51N5O6 | 577.76 | 2,1,3-Benzoxadiazole Hexanamide deriv.; [R-[R,R-(E)]]-N-[2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-4-benzofurazanyl)amino]-hexanamide
... |
| N-(NBD-Aminohexanoyl) D-erythro-Sphingosine | N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide; N-[(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)aminocaproyl]sphingosine; NBD-C 6Cer; | 94885-02-6 | C30H49N5O6 | 575.74 | N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide; N-[(7-Nitrobenz-2-oxa-1,3-diazol-4... |
| N-(NBD-Aminolauroyl)safingol | N-​[(1S,​2S)​-​2-​Hydroxy-​1-​(hydroxymethyl)​heptadecyl]​-​12-​[(7-​nitro-​2,​1,​3-​benzoxadiazol-​4-​yl)​amino]​-dodecanamide | 474943-07-2 | C36H63N5O6 | 661.92 | N-​[(1S,​2S)​-​2-​Hydroxy-​1-​(hydroxymethyl)​heptadecyl]​-​12-​[(7-​nitro-​2,​1,​3-​benzoxadiazol-​4-​yl)​amino... |
| 3-hexanoyl-NBD Cholesterol | Cholest-5-en-3-ol (3beta)-6-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoate | 201731-19-3 | C39H58N4O5 | 662.9 | Cholest-5-en-3-ol (3beta)-6-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoate
|
Page 7296 of 10017